SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs
7 references·4 citing·47 second hop
Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs (2010)Continental Divide? The Attitudes of US a…Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists (2010)Cancer Therapy Costs Influenc…Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions (2009)Using Effectiveness and Cost-…Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial (2009)Prospective Cost-Effectivenes…American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)American Society of Clinical …Medical Oncologists' Views on Communicating With Patients About Chemotherapy Costs: A Pilot Survey (2007)Medical Oncologists' Views on…Do Oncologists Believe New Cancer Drugs Offer Good Value? (2006)Do Oncologists Believe New Ca…Response rates to mail surveys published in medical journals (1997)Response rates to mail survey…Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study (2019)Conversations About Financial…The Implications of Out-Of-Pocket Cost of Cancer Treatment in the USA: A Critical Appraisal of the Literature (2014)The Implications of Out-Of-Po…Patient and oncologist discussions about cancer care costs (2013)Patient and oncologist discus…Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey (2012)Increasing response rates fro…Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers (2010)Attributes and weights in health care priority setting: A systematic review of what counts and to what extent (2015)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)A Quantitative Review of Research Design Effects on Response Rates to Questionnaires (1983)Understanding The Decision to Participate in a Survey (1992)Estimating the Effect of Incentives on Mail Survey Response Rates: A Meta-Analysis (1993)Scientists behaving badly (2005)A guide for the design and conduct of self-administered surveys of clinicians (2008)Exploring physician specialist response rates to web-based surveys (2015)Prospect Theory: An Analysis of Decision under Risk (1979)Prospect theory: An analysis of decision under risk (1988)Preserving the Physician-Patient Relationship in the Era of Managed Care (1995)Understanding Patients' Attitudes Toward Communication About the Cost of Cancer Care (2012)A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment (2016)Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance (2018)Physician response to surveys A review of the literature (2001)Methods to increase response to postal and electronic questionnaires (2009)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)Oncology navigators’ perceptions of cancer-related financial burden and financial assistance resources (2017)The burden of out of pocket costs and medical debt faced by households with chronic health conditions in the United States (2018)The patient-level effect of the cost of Cancer care – financial burden in German Cancer patients (2020)Basics of Qualitative Research: Grounded Theory Procedures and Techniques. (1992)Health Behavior and Health Education: Theory, Research, and Practice (1992)Basics of Qualitative Research: Grounded Theory Procedures and Techniques (1993)Predictors of financial difficulties and work modifications among cancer survivors in the United States (2015)Use and Misuse of the Term “Cost Effective” in Medicine (1986)Systematic Overview of Cost-Utility Assessments in Oncology (2000)Medicare and Cost-Effectiveness Analysis (2005)Healthcare Expenditure Burden Among Non-elderly Cancer Survivors, 2008–2012 (2015)Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters (2017)Willingness to Pay for a Quality-adjusted Life Year (2000)National Institute for Clinical Excellence and its value judgments (2004)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Preferences for cancer treatments: an overview of methods and applications in oncology (2012)Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer (2015)Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over Time (2018)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists (2013)Medical Care Costs: How Much Welfare Loss? (1992)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Association of Insurance with Cancer Care Utilization and Outcomes (2008)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)
this work references cited by second hop

References

  • 1997Response rates to mail surveys published in medical journals2,108 cited
  • 2009American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care638 cited
  • 2009Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions343 cited
  • 2007Medical Oncologists' Views on Communicating With Patients About Chemotherapy Costs: A Pilot Survey194 cited
  • 2006Do Oncologists Believe New Cancer Drugs Offer Good Value?187 cited
  • 2010Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists143 cited
  • 2009Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial139 cited

Cited by

  • 2012Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey112 cited
  • 2014The Implications of Out-Of-Pocket Cost of Cancer Treatment in the USA: A Critical Appraisal of the Literature73 cited
  • 2013Patient and oncologist discussions about cancer care costs60 cited
  • 2019Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study57 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work